IRIS
RUGGIERI, Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.840
AS - Asia 2.618
EU - Europa 2.398
SA - Sud America 729
Continente sconosciuto - Info sul continente non disponibili 175
AF - Africa 137
OC - Oceania 4
Totale 12.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.712
SG - Singapore 1.128
IT - Italia 822
CN - Cina 597
BR - Brasile 578
HK - Hong Kong 304
SE - Svezia 286
RU - Federazione Russa 259
DE - Germania 235
UA - Ucraina 203
VN - Vietnam 175
FR - Francia 168
FI - Finlandia 159
GB - Regno Unito 110
IN - India 86
BD - Bangladesh 74
CA - Canada 65
CI - Costa d'Avorio 62
AR - Argentina 44
JP - Giappone 37
ID - Indonesia 35
MX - Messico 34
IQ - Iraq 31
TR - Turchia 27
VE - Venezuela 26
EC - Ecuador 24
ES - Italia 23
ZA - Sudafrica 23
BE - Belgio 20
PH - Filippine 20
PK - Pakistan 20
PL - Polonia 20
CO - Colombia 19
NL - Olanda 19
IE - Irlanda 18
AT - Austria 13
PY - Paraguay 12
SA - Arabia Saudita 12
TN - Tunisia 11
UZ - Uzbekistan 11
JO - Giordania 10
KE - Kenya 10
LT - Lituania 9
MA - Marocco 9
CL - Cile 8
EG - Egitto 8
IR - Iran 8
JM - Giamaica 8
PE - Perù 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
MY - Malesia 6
IL - Israele 5
PT - Portogallo 5
UY - Uruguay 5
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
OM - Oman 4
AL - Albania 3
AO - Angola 3
AU - Australia 3
DK - Danimarca 3
GT - Guatemala 3
NP - Nepal 3
PS - Palestinian Territory 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
HR - Croazia 2
KR - Corea 2
KZ - Kazakistan 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 12.717
Salva come PNG Salva come JPEG
Città #
Ashburn 627
Singapore 591
Chandler 522
Fairfield 500
Woodbridge 473
San Jose 464
Jacksonville 454
Hong Kong 304
Milan 268
Houston 267
Nyköping 220
Ann Arbor 214
Wilmington 198
Seattle 183
Beijing 172
Cambridge 171
Council Bluffs 162
Los Angeles 122
Lawrence 107
Roxbury 103
Nanjing 102
Lauterbourg 101
Bari 96
Dallas 91
New York 88
Rome 84
Boardman 76
Des Moines 69
Chicago 65
Abidjan 62
Columbus 58
Helsinki 56
Santa Clara 56
Ho Chi Minh City 54
Brooklyn 48
Munich 48
Buffalo 46
Inglewood 42
Princeton 40
São Paulo 40
North Bergen 34
Marseille 33
Hanoi 31
Tokyo 31
Salt Lake City 29
San Diego 28
Nanchang 25
Rio de Janeiro 24
Figino 23
Jiaxing 23
Shenyang 23
Moscow 22
Brussels 20
Frankfurt am Main 20
Tianjin 20
Turin 20
Falkenstein 19
Dublin 18
Hebei 18
Belo Horizonte 17
Chennai 17
Clifton 17
Jakarta 17
Toronto 17
Warsaw 17
Miami 16
Montreal 15
Phoenix 15
Mexico City 14
Orem 14
Dearborn 13
London 13
Nuremberg 13
San Francisco 13
Secaucus 13
Elk Grove Village 12
Johannesburg 12
Mottola 12
Norwalk 12
Pune 12
Augusta 11
Baghdad 11
Da Nang 11
Denver 11
Naples 11
Stockholm 11
Tampa 11
Tashkent 11
Dong Ket 10
El Paso 10
Guangzhou 10
Haiphong 10
Assisi 9
Atlanta 9
Bologna 9
Caracas 9
Changsha 9
Imbersago 9
Manchester 9
Nairobi 9
Totale 8.406
Salva come PNG Salva come JPEG
Nome #
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 370
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study 288
Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity. 189
Age-related changes of serum N-acetyl-aspartate in healthy controls. 189
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 188
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 183
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 181
Host-Cell Type Dependent Features of Recombinant Human Aquaporin-4 Orthogonal Arrays of Particles-New Insights for Structural and Functional Studies 174
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 173
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of Multiple Sclerosis 165
Development of an aquaporin-4 orthogonal array of particle-based ELISA for neuromyelitis optica autoantibodies detection 164
IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism 160
Cerebrospinal fluid analysis and the determination of oligoclonal bands 156
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 156
Glatiramer Acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from Multiple Sclerosis patients 155
ANTINFLAMMATORY EFFECTS OF RIFNB-1B IN MULTIPLE SCLEROSIS: LONGITUDINAL CHANGES OF THE SERUM SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1), TNFA AND T-CELL SUBSETS 155
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 155
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 154
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 153
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis 152
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis. 151
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels 148
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 147
A population-based surveillance Italian study of Interferon beta treatment in Multiple Sclerosis patients: relationships between neutralizing antibodies production and clinical outcomes 135
B and T Immunoregulation: A New Insight of B Regulatory Lymphocytes in Autism Spectrum Disorder 132
Serum levels of N-acetylaspartate in Huntington's disease: Preliminary results. 127
CHANGES OF NAIVE AND EFFECTOR/MEMORY T-CELL SUBSETS AND SERUM SOLUBLE ICAM-1 INDUCED BY RIFNB-1B IN MS 125
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 125
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 125
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method 124
Analisi fenotipica di linfociti T di pazienti con Sclerosi Multipla (SM) nel sangue periferico ed in coltura con e senza aggiunta di mitogeni 123
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis. 122
Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding 122
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 121
Beta Amyloid 1-40 peptide selectively downregulates MMP-9 production in differentiated SH-SY5Y neuronal cell line 120
Antinflammatory effects of rIFNb-1b in multiple sclerosis: longitudinal changes of the serum soluble Intercellular Adhesion Molecule-1 (sICAM-1), TNFa and T-cell subsets 120
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 119
Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy 119
Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica 118
Serum levels of N-acetyl-aspartate in migraine and tension-type headache. 115
A LONGITUDINAL ANALYSIS OF SERUM SOLUBLE ICAM-1 (SICAM-1), TNFA AND T-CELL SUBSETS IN MULTIPLE SCLEROSIS (MS) PATIENTS DURING RIFNB-1B TREATMENT 114
Serum levels of N-acetyl-aspartate in migraine and tension-type headache. 113
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 112
Neurofilament ELISA validation 112
Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A 111
Correlations between neutralizing antibodies production and clinical outcomes: analysis in a population-based surveillance italian study of interferon beta treatment in multiple sclerosis patients 111
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing 110
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 110
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. 108
ANALISI DEL POLIMORFISMO GENICO E DELLA PRODUZIONE LIMFOMONOCITARIA DI TNF-ALPHA IN PAZIENTI CON SCLEROSI MULTIPLA (SM) 107
MMP-9 and 2 activities and TIMPs in MS: differences between early and chronic disease 105
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 105
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 104
Glatiramer acetate in multiple sclerosis: a review 104
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients 103
Italian studies on early-onset multiple sclerosis: the present and the future 103
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 102
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 100
Serum Soluble ICAM-1 and Gelatinase B Novel Markers of Clinical Efficacy of the RIFN-beta-1b in Relapsing-Remitting Multiple Sclerosis 100
Neutralizing antibodies during treatment of relapsing Multiple Sclerosis patients with three interferon beta: correlation with clinical outcomes 98
Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients 98
Interferone beta (IFNb) e barriera emato-encefalica nella Sclerosi Multipla: effetto su molecole di adesione e metalloproteasi 98
UN ANNO DI TRATTAMENTO CON INTERFERONE B-1B INCREMENTA I LIVELLI SIERICI DI SICAM-1 E RIPRISTINA LA FUNZIONE SOPPRESSORIA DEI T-LINFOCITI IN PAZIENTI CON SM RELAPSING-REMITTING 97
Novel anti-inflammatory properties of rIFN-beta-1b in RR MS: recovery of T-suppression and increase of serum sICAM-1 96
Bcl-2, Bax, Cytocrome-c mitochondria mediated apoptosis proteins during Glatiramer Acetate treatment in Multiple Sclerosis patients 96
Serum MMPs and TIMPs in Multiple Sclerosis: differences between early and chronic disease 95
CHANGES OF SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1) LEVELS INDUCED BY CORTICOSTEROIDS AND RIFN-BETA-1B IN MULTIPLE SCLEROSIS AND GUILLAIN-BARRÉ SYNDROME 94
N-Acetyl-Aspartate (NAA) and Neurofilament Light-Chain (NF-L) in Biological Fluids as Markers of Neurodegeneration in ALS 94
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy 93
RIFNB DOWNREGULATES TNFA-INDUCED ICAM-1 EXPRESSION ON BRAIN MICROVASCULAR ENDOTHELIAL CELLS (BEMC) AND INCREASES SERUM SOLUBLE ICAM-1 (SICAM-1) IN RR MS 91
Modificazioni dei livelli sierici di ICAM-1 solubile (sICAM.1), e Gelatinasi A e B e sottopopolazioni T-linfocitarie di sangue periferico indotte dal trattamento con interferone-beta-1b (IFN-BETA-1B) in pazienti con Sclerosi Multipla (SM) Relapsing-Remitting (RR): Relazione con la produzione di anticorpi neutralizzanti anti-interferone (NABs) 91
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis 90
Standard (SD) and triple dose (TD) gadolinium (Gd) enhancing lesions are associated with a similar degree of MMP-9 and TIMP-1 involvement at the blood-brain barrier (BBB) level in Multiple Sclerosis (MS) 90
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 89
Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke 88
STUDIO IN VITRO DI POPOLAZIONI LINFOMONOCITARIE CD45R+ E CD29+ 87
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy 87
Decreased levels of serum gelatinase B in MS patients during the treatment with rIFN-beta-1b 86
RIFN BETA-1A AND SICAM-1 EFFECTS ON CD4+CD45RO+ PBTLS EXPRESSING LFA-1 IN RR MS: IN VIVO AND IN VITRO STUDY 85
Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies 85
Changes of serum soluble ICAM-1 and matrix metalloproteinas-9 (MMP-9) induced by Interferon beta-1b treatment in relapsing-remitting multiple sclerosis 84
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes 84
LFA-1 expressing CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNb-1a 83
LFA-1 EXPRESSION ON CD4+CD45RO+ PBTLS DURING RIFN-BETA-1A TREATMENT IN RR MS: IN VIVO AND IN VITRO STUDY 81
LFA-1 EXPRESSION ON CD4+CD45RO+ PERIPHERAL BLOOD T-LYMPHOCYTES: IN VIVO AND IN VITRO CHANGES INDUCED BY RECOMBINANT INTERFERON-BETA-1A (RIFN-BETA-1A) IN RELAPSING-REMITTING (RR) MULTIPLE SCLEROSIS (MS) 80
Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics 80
VALUTAZIONE POST-MARKETING DI SICUREZZA DELL' INTERFERONE-BETA (IFN-BETA) IN PAZIENTI CON SCLEROSI MULTIPLA (SM) RELAPSING-REMITTING (RR) NELL' ITALIA MERIDIONALE. RICERCA SCIENTIFICA DELLE 79
IFNB-1B TREATMENT EFFECTS ON SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 SERUM LEVELS AND T-CELL SUBSETS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS. 12TH CONGRESS OF THE EUROPEAN COMMITTE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS (ECTRIMS) 79
MMPs and TIMPs involvement at the blood-brain barrier level in MS: comparison between patients enhancing with different doses of gadolinium during rIFNb-1a treatment 79
MMPS AND TIMPS ARE DIFFERENTLY RELATED TO MS COURSES AND PHASES OF THE DISEASE 78
Changes of serum sICAM-1 and MMP-9 induced by rIFN beta-1b treatment in relapsing-remitting MS 78
Serum N-acetyl-aspartate in Relapsing Remitting Multiple Sclerosis 77
NMO-IgG and AQP-4 antibodies in different demyelinating disease phenotypes: correlations with clinical and paraclinical parameters 76
Soluble Intercellular Adhesion Molecule-1 in serum and cerebrospinal fluid of demyelinating disease of the central and peripheral nervous system 74
SOPLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1) NEL SIERO E LIQUOR DI PAZIENTI CON SCLEROSI MULTIPLA REMITTENTE CLINICAMENTE ATTIVA: CORRELAZIONI CON LESIONI RMI CHE ASSUMONO GADOLINIO E CON PARAMETRI LIQUORALI 74
Matrix metalloproteinases and disease corse in Multiple Sclerosis 74
CSF and serum soluble adhesion molecules in Multiple Sclerosis 72
null 72
Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system 71
null 71
Totale 11.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022539 0 0 19 19 25 35 28 42 40 21 135 175
2022/20231.298 172 121 83 133 157 176 11 145 234 1 30 35
2023/2024391 47 70 24 24 24 90 28 21 4 10 3 46
2024/20252.092 62 36 146 55 46 152 155 187 67 129 443 614
2025/20264.330 621 206 286 453 458 241 459 135 421 410 135 505
2026/2027624 269 178 177 0 0 0 0 0 0 0 0 0
Totale 12.901